{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:17:44Z","timestamp":1792646264048,"version":"4.5.0"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2002,5,28]]},"DOI":"10.1212\/wnl.58.10.1461","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T09:58:00Z","timestamp":1336903080000},"page":"1461-1470","source":"Crossref","is-referenced-by-count":157,"title":["Plexiform neurofibromas in NF1"],"prefix":"10.1212","volume":"58","author":[{"given":"R. J.","family":"Packer","sequence":"first","affiliation":[{"name":"From the Departments of Neurology and Pediatrics (Dr. Packer) and Radiology (Neuroradiology) (Dr. Vezina), Children\u2019s National Medical Center, George Washington University, Washington, DC; Department of Neurology (Dr. Gutmann), Washington University School of Medicine, and Neurofibromatosis Program, St. Louis Children\u2019s Hospital, St. Louis, MO; Department of Neurology (Dr. Rubenstein), Mount Sinai School of Medicine, and National Neurofibromatosis Foundation (Dr. Small), New York, NY; Department of..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. H.","family":"Gutmann","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology and Pediatrics (Dr. Packer) and Radiology (Neuroradiology) (Dr. Vezina), Children\u2019s National Medical Center, George Washington University, Washington, DC; Department of Neurology (Dr. Gutmann), Washington University School of Medicine, and Neurofibromatosis Program, St. Louis Children\u2019s Hospital, St. Louis, MO; Department of Neurology (Dr. Rubenstein), Mount Sinai School of Medicine, and National Neurofibromatosis Foundation (Dr. Small), New York, NY; Department of..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rubenstein","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology and Pediatrics (Dr. Packer) and Radiology (Neuroradiology) (Dr. Vezina), Children\u2019s National Medical Center, George Washington University, Washington, DC; Department of Neurology (Dr. Gutmann), Washington University School of Medicine, and Neurofibromatosis Program, St. Louis Children\u2019s Hospital, St. Louis, MO; Department of Neurology (Dr. Rubenstein), Mount Sinai School of Medicine, and National Neurofibromatosis Foundation (Dr. Small), New York, NY; Department of..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Viskochil","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology and Pediatrics (Dr. Packer) and Radiology (Neuroradiology) (Dr. Vezina), Children\u2019s National Medical Center, George Washington University, Washington, DC; Department of Neurology (Dr. Gutmann), Washington University School of Medicine, and Neurofibromatosis Program, St. Louis Children\u2019s Hospital, St. Louis, MO; Department of Neurology (Dr. Rubenstein), Mount Sinai School of Medicine, and National Neurofibromatosis Foundation (Dr. Small), New York, NY; Department of..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. A.","family":"Zimmerman","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology and Pediatrics (Dr. Packer) and Radiology (Neuroradiology) (Dr. Vezina), Children\u2019s National Medical Center, George Washington University, Washington, DC; Department of Neurology (Dr. Gutmann), Washington University School of Medicine, and Neurofibromatosis Program, St. Louis Children\u2019s Hospital, St. Louis, MO; Department of Neurology (Dr. Rubenstein), Mount Sinai School of Medicine, and National Neurofibromatosis Foundation (Dr. Small), New York, NY; Department of..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Vezina","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology and Pediatrics (Dr. Packer) and Radiology (Neuroradiology) (Dr. Vezina), Children\u2019s National Medical Center, George Washington University, Washington, DC; Department of Neurology (Dr. Gutmann), Washington University School of Medicine, and Neurofibromatosis Program, St. Louis Children\u2019s Hospital, St. Louis, MO; Department of Neurology (Dr. Rubenstein), Mount Sinai School of Medicine, and National Neurofibromatosis Foundation (Dr. Small), New York, NY; Department of..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Small","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology and Pediatrics (Dr. Packer) and Radiology (Neuroradiology) (Dr. Vezina), Children\u2019s National Medical Center, George Washington University, Washington, DC; Department of Neurology (Dr. Gutmann), Washington University School of Medicine, and Neurofibromatosis Program, St. Louis Children\u2019s Hospital, St. Louis, MO; Department of Neurology (Dr. Rubenstein), Mount Sinai School of Medicine, and National Neurofibromatosis Foundation (Dr. Small), New York, NY; Department of..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Korf","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology and Pediatrics (Dr. Packer) and Radiology (Neuroradiology) (Dr. Vezina), Children\u2019s National Medical Center, George Washington University, Washington, DC; Department of Neurology (Dr. Gutmann), Washington University School of Medicine, and Neurofibromatosis Program, St. Louis Children\u2019s Hospital, St. Louis, MO; Department of Neurology (Dr. Rubenstein), Mount Sinai School of Medicine, and National Neurofibromatosis Foundation (Dr. Small), New York, NY; Department of..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","unstructured":"Friedman   JM Gutmann   DH MacCollin   M et al.  Neurofibromatosis: phenotype natural history and pathogenesis.   3rd ed.   Baltimore:   Johns Hopkins University Press 1999."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/111.6.1355"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<31::AID-AJMG7>3.0.CO;2-W"},{"key":"e_1_3_2_5_2","unstructured":"Woodruff   JM Lourea   HP Louis   DN Scheitauer   BW.   Neurofibroma. In:  Kleihues  P Cavenee  WK eds.  World Health Organization classification of tumours pathology and genetics of tumors of the nervous system.   Lyon:   IARC Press 2000:  167\u2013168."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.11.1433"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.5-6-477"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(20000515)92:2<132::AID-AJMG10>3.0.CO;2-6"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-8628(20000828)93:5<388::AID-AJMG8>3.0.CO;2-#"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930215)71:4<1247::AID-CNCR2820710413>3.0.CO;2-S"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002340050814"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.34.3.184"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0995-90"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2264(199903)24:3<283::AID-GCC15>3.0.CO;2-K"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)61673-2"},{"key":"e_1_3_2_16_2","first-page":"1056","volume":"9","year":"2000","unstructured":"Rutkowski J, Wu K, Gutmann DH, et al. Multiple mechanisms of benign tumor formation in neurofibromatosis type 1. Hum Mol Genet . 2000; 9: 1056\u20131066.","journal-title":"Hum Mol Genet"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0996-110"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1086\/515504"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/9.20.3055"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90024-9"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90151-4"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M001702200"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/59.9.759"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(86)90156-1"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00609.x"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.191.1.181"},{"key":"e_1_3_2_27_2","first-page":"245","volume":"60","year":"1989","unstructured":"Perisio PM, Brooks JJ. Expression of growth factors and growth factor receptors in soft tissue tumors: implications for the autocrine hypothesis. Lab Invest . 1989; 60: 245\u2013253.","journal-title":"Lab Invest"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI7610"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70158-6"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.111.2.645"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63992-2"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00133486"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3780293"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100249900138"},{"key":"e_1_3_2_35_2","first-page":"19","volume":"427","year":"1995","unstructured":"Kindblom LG, Ahlden M, Meis-Kindblom JM, Stenman G. Immunohistochemical and molecular analysis of p53, mdm2, proliferating cell nuclear antigen and Ki67 in benign and malignant nerve sheath tumors. Virchows Arch . 1995; 427: 19\u201326.","journal-title":"Virchows Arch"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/106.3.282"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65507-1"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65508-3"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65504-6"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.286.5447.2172"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.286.5447.2176"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)70092-1"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1987.01660320053011"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1993.01680260047004"},{"key":"e_1_3_2_45_2","unstructured":"Riccardi   VM.   The potential role of trauma and mast cells in the pathogenesis of neurofibromas. In:  Ishibashi  Y Hori  Y eds.  Tuberous sclerosis and neurofibromatosis: epidemiology pathophysiology biology and management.   New York:   Elsevier 1990:  167\u2013190."},{"key":"e_1_3_2_46_2","first-page":"12","volume":"54","year":"2000","unstructured":"Gupta A, Cohen B, Ruggierri P, et al. A phase I study of thalidomide for the treatment of plexiform neurofibroma in patients with neurofibromatosis 1 (NF1). Neurology . 2000; 54: 12\u201313. Abstract.","journal-title":"Neurology"},{"key":"e_1_3_2_47_2","first-page":"3569","volume":"55","year":"1995","unstructured":"Yan N, Ricca C, Fletcher J, et al. Farnesyl transferase inhibitors block the neurofibromatosis type 1 (NF1) malignant phenotype. Cancer Res . 1995; 55: 3569\u20133575.","journal-title":"Cancer Res"},{"key":"e_1_3_2_48_2","first-page":"L311","volume":"276","year":"1999","unstructured":"Gurujeyalakshmi G, Hollinger MA, Giri SN. Pirfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fibrosis at the translational level. Am J Physiol . 1999; 276: L311\u2013L318.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_49_2","first-page":"211","volume":"189","year":"1998","unstructured":"Iyer SN, Gurujeyalakshmi G, Giri SN. Effects of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. J Pharmacol Exp Ther . 1998; 189: 211\u2013218.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.159.4.9805017"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970715)80:2<334::AID-CNCR22>3.0.CO;2-U"},{"key":"e_1_3_2_52_2","first-page":"1011","volume":"19","year":"1998","unstructured":"Maravilla KR, Bowen BC. Imaging of the peripheral nervous system: evaluation of peripheral neuropathy and plexopathy. AJNR . 1998; 19: 1011\u20131023.","journal-title":"AJNR"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.68.3.353"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03520080061045"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/hec.4730020305"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.58.10.1461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T14:23:39Z","timestamp":1711635819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.58.10.1461"}},"subtitle":["Toward biologic-based therapy"],"short-title":[],"issued":{"date-parts":[[2002,5,28]]},"references-count":54,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2002,5,28]]}},"alternative-id":["10.1212\/WNL.58.10.1461"],"URL":"https:\/\/doi.org\/10.1212\/wnl.58.10.1461","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,5,28]]}}}